Base Editing in Human Embryos: Gentler but Mosaic
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Scientists used base editing, a newer, more precise CRISPR variant, in early human embryos to study genes active during the earliest stages of human development, per a study published in Nature.
- The research suggests base editing is gentler than earlier CRISPR methods, sidestepping the chromosome damage that has previously raised safety concerns in embryo editing work.
- Despite the precision gain, the edited embryos frequently developed as mosaics, carrying a mix of edited and unedited cells.
- STAT reporters Andrew Joseph and Megan Molteni covered the findings, framing them as a development reigniting ethical debates around embryo editing.
Why it matters: The advance pushes base editing past the chromosome-damage barrier that stalled earlier CRISPR embryo work, but the persistent mosaic problem—embryos carrying a mix of edited and unedited cells—keeps the safety bar for any therapeutic use unmet.
